Nanjing Chemlin Chemical Industry Co., Ltd. will make a grand appearance at the 2023 Nanjing International Chemical Exhibition, with booth number A08. As a leading chemical enterprise in the industry, we will showcase our latest products and technological solutions, covering fine chemicals, environmentally friendly materials, and customized services. During the exhibition, our professional team will provide you with a detailed introduction to the product advantages and share the latest industry trends. We sincerely invite partners from all walks of life to visit our booth, discuss development together, and create the future together! 双语对照 笔记
Recently, Chemlin Biopharmaceutical Company has made a series of significant breakthroughs in drug research and development, successfully launching multiple innovative drugs covering multiple treatment areas such as cancer, rare diseases, and chronic diseases. These achievements not only mark the company's leading position in biopharmaceutical technology, but also bring new treatment options and hope to patients worldwide.
Recently, Professor Zhang Guoqing's team from the National Research Center for Microscale Matter Science at the University of Science and Technology of China in Hefei reported the discovery of a new mode of interaction between organic molecules: a stable photo induced charge transfer complex can be formed between aromatic imides and fatty amines. The properties and formation process of this complex were systematically studied through steady-state and time-resolved emission spectroscopy, absorption spectroscopy, mass spectrometry, paramagnetic resonance spectroscopy, and other methods. It was demonstrated that this complex can be used in fields such as photo induced polymerization, carbon dioxide photoreduction, and ultraviolet energy storage. The achievement was published in Chem under the title "Trapping Highly Reactive Photo Induced Charge Transfer Complex Between Amine and Imide by Light".
Recently, Chemlin Biopharmaceutical Company, as an industry leader, made a grand appearance at the 2023 International Biopharmaceutical Exhibition, becoming the focus of attention from the audience.
